Inflection Biosciences Announces Poster Presentation at the 2013 AACR-NCI-EORTC Conference
Dublin, Ireland, October 17, 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...
Inflection Biosciences Announces Poster Presentation at the 2013 AACR-NCI-EORTC Conference
Dr Michael O’Neill, Inflection Biosciences' Director of R&D interviewed by Pharma Television
Inflection Licenses Preclinical Oncology Programs from the Spanish National Cancer Research Centre
Inflection Biosciences Selected to Present at International Investor Forum
Inflection Biosciences to attend 24th Annual EORTC-NCI-AACR Symposium